New review published in @natimmunol.nature.com by #IDEALpediatrics research group including Drs. Paolo Palma, Donna Farber, Liza Konnikova and @droferlevy.bsky.social identifies the first 1,000 days as a decisive window for immune development. Read more here: pubmed.ncbi.nlm.nih.gov/42174266/
@precvaccines.bsky.social
Thank you to the incredible panel of researchers who presented at the Immune Development in Early Life Hot Topic Symposium at @pasmeeting.bsky.social #PAS2026 L to R: Dr. Xiaobin Wang, Dr. Ofer Levy, Dr. Oluwabunmi Olaloye, Dr. Octavio Ramilo, Dr. Paolo Palma. #vaccines #IDEAL #EarlyLifeImmunity
It was our pleasure to host Dr. Mercy Prabhudas, our NIH @niaidnews.bsky.social Program Officer at our @precvaccines.bsky.social space today! @droferlevy.bsky.social @joanndarce.bsky.social
Members of our Data Management and Analysis team had a great time at NextGenOmics, Spatial & Data US! Joann Diray Arce, PhD gave a talk on ImmuneVISTA and MultiOMICs in #vaccine research #NGOUS2026 #OGPREMED #vaccines
At the World Vaccine Congress workshop on adjuvant science; L to R: @precvaccines.bsky.social Director @droferlevy.bsky.social; Drs. David Burkhardt, Wolfgang Leitner, Roland Ventura, Adolfo Garcia Sastre & Ken Ishii @utokyoofficial.bsky.social #WVCUSA #WVC2026 #WVCDC
Study from #NIH supported @hipcproject.bsky.social compares immunogenicity of neonatal HepatitisB & BCG #vaccines given alone & in combination. @precvaccines.bsky.social is grateful to our participants & EPIC collaborators, @mrcunitgambia.bsky.social, PNG Institute of Medical Research bit.ly/4c1cu4F
A randomized prospective study of neonatal hepatitis B vaccine immunogenicity in The Gambia and Papua New Guinea
Protection of newborns from infection can be achieved through maternal or vaccine-induced antibodies, but the factors influencing vaccine protection (correlate of protection) and subsequent infant imm...
bit.ly
Dr. Kinga Smolen with Drs. Diana Bianchi M.D. and Sallie Permar at the Paediatric Research for the Future of Children: A Global Forum hosted by European Society for Paediatric Research (ESPR) and Society for Pediatric Research #vaccines #vaccinessavelives #PRFC2026
Our own Soumik Barman presented last week at the Sony Biotechnology Inc. Spectral Seminar at the @broadinstitute.org. His talk: ”Deep phenomics using Spectral Flow Cytometry: OMIP-111 and beyond” focused on profiling of innate and adaptive immune responses across murine, primates, and humans.
Thank you to The New York Academy of Sciences for hosting a great event on Bacterial Vaccines and Immune Therapies! #vaccines @droferlevy.bsky.social
@joanndarce.bsky.social is presenting tomorrow at the virtual NIAID "Systems Immunology in Transplantation" Symposium. Register for free here: forms.office.com/pages/respon...
Ask global public health experts including @droferlevy.bsky.social "Everything You're Afraid to Ask about Vaccine Science" on Tuesday January 20th at 7 pm EST at the @museumofscience.bsky.social! #vaccines Register here: www.mos.org/events/unfil...
Our #IMPACC research in @pnas.org helps explain why people experience #Covid_19 so differently. @joanndarce.bsky.social @naama-kanarek.bsky.social @bostonchildrens.bsky.social @harvardmed.bsky.social @meduniwien.ac.at @yalemed.bsky.social @broadinstitute.org #NIAID pubmed.ncbi.nlm.nih.gov/41410771/
MTHFR allele and one-carbon metabolic profile predict severity of COVID-19 - PubMed
While the public health burden of SARS-CoV-2 infection has lessened due to natural and vaccine-acquired immunity, emergence of less virulent variants, and antiviral medications, COVID-19 continues to take a significant toll. There are thousands of new hospitalizations and hundreds of deaths per week …
pubmed.ncbi.nlm.nih.gov
PVP Director, @droferlevy.bsky.social, was featured in Smithsonian Magazine last week, sharing expert insights on #COVID-19 vaccines. www.smithsonianmag.com/articles/six...
Six Questions About Covid-19 Vaccines, Answered
Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when
smithsonianmag.com
PVP Director, @droferlevy.bsky.social, was interviewed by Michael Rosenfield at NBC News regarding the new #CDC #vaccine recommendations: www.nbcboston.com/news/local/h...
Health experts weigh in on impact of CDC changing COVID vaccine recommendations
The CDC will no longer recommend the COVID vaccine for healthy children or healthy pregnant women, Health and Human Services Secretary Robert F. Kennedy Jr. announced.
nbcboston.com
@droferlevy.bsky.social, PVP Director, was quoted in @theatlantic.com by @katherinejwu.com about how the new #FDA framework for #COVIDvaccines will impact children: www.theatlantic.com/health/archi...
theatlantic.com
Published in the Journal of Clinical Investigation! PVP members Drs Asimenia Angelidou, Kinga Smolen, and @droferlevy.bsky.social collaborated with Troy Martin at Fred Hutchinson in developing an HVTN clinical trial of an infant HIV vaccine. www.jci.org/articles/vie... #HelpEndHIV
JCI - Safety and implementation of phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns
jci.org
@precvaccines.bsky.social Director @droferlevy.bsky.social was quoted today in the @nytimes.com by Christina Jewett regarding the new #HHS policy on placebo-controlled #vaccine trials: www.nytimes.com/2025/05/01/u...
Kennedy Issues Demands for Vaccine Approvals That Could Affect Fall Covid Boosters (Gift Article)
The agency suggested that clinical trials in humans may be required for updated Covid shots, raising questions about whether they will be available in the fall.
nytimes.com
Vaccinology: Getting our modernization act together. Viewpoint from Ofer Levy (@droferlevy.bsky.social) @precvaccines.bsky.social on the implications of the new FDA Modernization Act 2.0 for accelerating drug and #vaccine discovery and development. rupress.org/jem/article/... #PrecVaccinesNetwork
In @jem.org, Ofer Levy @precvaccines.bsky.social (Boston Children’s Hospital) reflects on implications of the new FDA Modernization Act 2.0 on accelerating drug and #vaccine discovery and development. rupress.org/jem/article/... #PrecVaccinesNetwork
PVP Director, @droferlevy.bsky.social , reflects on how @fda.gov Modernization Act 2.0 will enhance and accelerate precision drug and vaccine development via human in vitro modeling, systems biology & artificial intelligence #AI as published in @jem.org #Vaccines rupress.org/jem/article/...
Vaccinology: Getting our modernization act together | Journal of Experimental Medicine | Rockefeller University Press
Ofer Levy, Director, Precision Vaccines Program at Boston Children’s Hospital, reflects on implications of the new FDA Modernization Act 2.0 on acceleratin
rupress.org
The @precvaccines.bsky.social team is setting up and looking forward to World Vaccine Conference in Washington DC #WVC2025 @vaccinenation
Ofer Levy @precvaccines.bsky.social (Boston Children’s Hospital) reflects on implications of the new FDA Modernization Act 2.0 on accelerating drug and #vaccine discovery and development. rupress.org/jem/article/... #PrecVaccinesNetwork
The Boston Marathon is only 2 weeks away! 🏃♀️ Tytana Yap is running the #BostonMarathon with Boston Children's Hospital in support of PVP! Donate today to help Tytana reach her fundraising goal. #PrecVaccinesNetwork #BostonMarathon2025 secure.childrenshospital.org/site/TR/Acti...
Boston Marathon 2025: Support me fundraising for Boston Children's Hospital
I've joined the Miles for Miracles team because I am passionate about helping kids at Boston Children’s Hospital find lifesaving care, and give families hope. Will you help me reach my fundraising goa...
secure.childrenshospital.org
@droferlevy.bsky.social, PVP Director, is speaking at the World Vaccine Congress Washington on April 21-24, 2025! Register today using code BCH25 and save 25%! terrapinn.com/WVCDC/BCH2025 #WVCDC #WorldVaccineCongress
Congratulations to PVP team members, Drs Asimenia Angelidou, Maria Laura Mourao, and Oludare Odumade for their publication in The Pediatric Infectious Disease Journal! 👶 💉 #newborn #vaccine #PrecVaccinesNetwork journals.lww.com/pidj/Fulltex...
Trends in Neonatal Vaccination: A Ten-year Retrospective... : The Pediatric Infectious Disease Journal
everal vaccines at 2 months of age (regardless of the BW) including the first dose of the pneumococcal vaccine (PCV). However, adherence to these guidelines is often suboptimal, resulting in incomplet...
journals.lww.com
Registration for #IPVC2025 is now open! We hope to see you in Burlington, Vermont on 08-09 October! 🩹👩🔬 #PrecVaccinesNetwork junapr.regfox.com/2025-ipvc
Now more than ever, support for vaccine research is critical. Tytana Yap is running the Boston Marathon in support of PVP! Donate now to help Tytana reach her fundraising goal. #PrecVaccinesNetwork #BostonMarathon2025: secure.childrenshospital.org/site/TR/Acti...
Boston Marathon 2025: Support me fundraising for Boston Children's Hospital
I've joined the Miles for Miracles team because I am passionate about helping kids at Boston Children’s Hospital find lifesaving care, and give families hope. Will you help me reach my fundraising goa...
secure.childrenshospital.org
PVP Director, @droferlevy.bsky.social, was interviewed by Berkeley Lovelace at @nbcnews.com re #FDA's unexpected cancellation of VRBPAC Committee #influenza strain selection meeting. #fluvaccines #vaccines www.nbcnews.com/health/healt...
Could flu shot supply fall short this year? FDA's canceled meeting sparks worries
Flu vaccine makers may face a last-minute scramble to produce enough doses after an FDA advisory committee meeting was abruptly canceled.
nbcnews.com
Out now! Product & trial design considerations for an opioid vaccine in NPJ Vaccines with Drs Elissa Weitzman, David Dowling, and @droferlevy.bsky.social. #EndOverdose #OpioidCrisis #opioid www.nature.com/articles/s41...
Product and trial design considerations on the path towards a vaccine to combat opioid overdose - npj Vaccines
npj Vaccines - Product and trial design considerations on the path towards a vaccine to combat opioid overdose
nature.com
PVP is honored to partner with Ernst Lab at UMaryland Baltimore in publishing in Elsevier Vaccine: “BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice” by Dr. Matthew Sherman et al www.sciencedirect.com/science/arti...
BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice
Shigella spp. infection contributes significantly to the global disease burden, primarily affecting young children in developing countries. Currently,…
sciencedirect.com